Report Overview:
The Global Vaccines Market achieved a valuation of $43.80 Billion in 2022 and is anticipated to exceed $90.52 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 9.5% during the forecast period from 2024 to 2032.
Key Market Players:
GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), Sanofi SA (France), CSL Limited...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek